• br In spite of the relevant

  2022-09-08

  

   In spite of the relevant results, some points may be explored to improve our approach. For instance, we have not investigated all possible associations from among the 1512 attributes. More-over, the parameters required by the methods should be inves-tigated to establish the limits and best cond

• br Study of an effective correlation between the

  2022-09-08

  

  • Study of an effective correlation between the features that show the best classification rates with the histological proper-ties observed on the H&E images, as well as indications of non-relevant associations to classify the colorectal cancer; Fig. 1. A summary of the method for evaluating co

• br Fig Platinum chemotherapy drugs modestly

  2022-09-07

  

  Fig. 5. Platinum chemotherapy drugs modestly promote ICD in vivo. Mice were inoculated with mouse oral cancer (MOC1) MK-2206 killed in vitro by radiation (XRT, 100 Gy, positive control), mitoxantrone (MTX, 1 μg/ml × 72 h, positive control) oxaliplatin (OXP, 6 μg/ml × 72 h, LD90), or cisplatin (CDD

• br libres y pacientes segu an cumpliendo criterios de

  2022-09-07

  

  libres y 16 pacientes seguían cumpliendo criterios de radioterapia intraoperatoria como mono- terapia. En 7 pacientes se precisó administrar radioterapia glandular externa por no cumplir alguno de los criterios. Conclusiones: La cirugía oncoplástica asociada a radioterapia intraoperatori

• br Growing evidence indicates circRNAs play critical roles in reg

  2022-09-02

  

  Growing evidence indicates circRNAs play critical roles in reg-ulating gene expression by sequestering the miRNAs. For example, Fig. 7. Circ-EIF4G3 could serve as a sponge for miR-335. (a) The biotin-coupled probe pull-down assay was performed and the results showed miR-335 was detected in the

• br In conclusion hypoxia is capable of desensitizing

  2022-09-02

  

  In conclusion, hypoxia is capable of desensitizing human CRC GSK1838705A to oxaliplatin as well as promoting EMT and stemness. However, CA can  enhance the susceptivity of oxaliplatin by promoting apoptosis partly through inhibition of PI3K/Akt signaling and suppress EMT and stem-ness via in

• br acquired during in vitro culture also clearly

  2022-09-01

  

  acquired during in vitro culture also clearly co-localized with genome rearrangements (Figure 5A). Multiple kataegis foci composed exclusively of C>T mutations were acquired in the UNG-deficient BC-1 cell line (Figure 5A), indicating that forma-tion of UNG-mediated abasic sites is not required for

• br Table br Changes in insurance status stratified by

  2022-08-31

  

  Table 3 Changes in insurance status stratified by expanded versus nonexpanded states Expanded statesa Non-expanded statesb Non-Medicaid insurance 6689 a Expanded states are defined as states which have fully expanded Medicaid as of January 1, 2014; within the SEER database this is

• br Patient population br Patients aged e years

  2022-08-31

  

  Patient population Patients aged 19e64 years with newly diagnosed breast, cervical, uterine, or prostate cancer from January 2011 through December 2014 with known insurance status who were treated with brachytherapy were included in the analysis. Those 18 years and under were excluded due to ot

• br aDepartment of Pathology and Laboratory Medicine London

  2022-08-18

  

  aDepartment of Pathology and Laboratory Medicine London Health Sciences Centre, London, Ontario, Canada N6A 5A5 bDepartment of Oncology (Division of Radiation Oncology), London Regional Cancer Program, London, Ontario, Canada N6A 5W9 cDepartment of Oncology (Division of Medical Oncology), London

• br of the anionic nanogel to be internalized

  2022-08-18

  

  of the anionic nanogel to be internalized into the cell, and therefore the release of the drug could take place in the periphery of the CFTRinh-172 and the drug could accessto cytoplasm by diffusional transport. In a literature report on CDDP loaded in pH-thermal dual responsive anionic nanogels,

• br J R Brahmer C Lacchetti B J Schneider

  2022-08-17

  

  [114] J.R. Brahmer, C. Lacchetti, B.J. Schneider, M.B. Atkins, K.J. Brassil, J.M. Caterino, et al., Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Prac-tice Guideline, J. Clin. Oncol. 36 (17)

• br Cancer therapy br Cardio

  2022-08-17

  

  Cancer therapy Cardio-oncology Cardiotoxicity  Current therapy of advanced cancers is based on several modalities including radiotherapy, cytotoxic chemother-apy, molecularly targeted inhibitors and Poly(I:C) targeting immune checkpoints. All of those these modalities can negatively im

• Docosahexaenoic Acid br Gene expression analysis br Gene expression

  2022-08-15

  

  2.6. Gene expression analysis Gene expression was analyzed using the Mouse PanCancer Pathways Panel (XTeCSOeMPATH1-12) on the nCounter system (NanoString Technologies, Seattle, WA) [27] according to manufac-turer's instructions. Raw data were normalized to the stable house-keeping gene, which w

• br Up to now it has

  2022-08-11

  

  Up to now, it has been demonstrated that HY per se is able to in-crease protein expression of multidrug resistance protein 1 (MDR1) in LS-180V colon adenocarcinoma Echinomycin [21], multidrug resistance-asso-ciated protein 1 (MRP1) and BCRP in HT-29 colon adenocarcinoma cells [22,23], MRP1 in A27

181 records 2/13 page Previous Next 12345 Next 5 pages Last page